<DOC>
	<DOCNO>NCT02419313</DOCNO>
	<brief_summary>The scientific aim study investigate efficacy safety incobotulinumtoxinA ( Xeomin-Merz Pharmaceuticals ) tremor Parkinson‟s disease . Our hypothesis injection Xeomin muscle arm , forearm hand decrease tremor amplitude frequency lead improvement patient‟s function .</brief_summary>
	<brief_title>Investigation Efficacy Safety IncobotulinumtoxinA ( Xeomin ) Parkinson 's Tremor : A Customized Approach</brief_title>
	<detailed_description>This investigator initiate , randomize , double blind , placebo control , cross study support Merz pharmaceutical . Patients Parkinson‟s disease ( Yale Neurology Movement disorder clinic ) approach member research team ( PI sub-investigators ) see meet inclusion exclusion criterion wish participate study . If eligible consent participate study , series questionaires , examination treatment session .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>Inclusion Criteria . 1 . Age 18 year 2 . Both sexes 3. races/ethnic group . 4 . Meeting clinical diagnosis Parkinson 's disease presence moderate severe Parkinson tremor refractory standard medical treatment limit patient‟s functionality and/or pose significant discomfort . 5 . Subjects able read , speak , understand English . Exclusion Criteria . 1 . Existing significant acute medical condition ( i.e . cardiovascular , endocrine , hematologic , neoplastic , infectious , autoimmune disorder ) significant swallow breathe difficulty . 2 . Pregnancy plan pregnancy ( determined urine pregnancy test ) . 3 . Active breast feeding . 4 . Enrollment clinical trial ( currently within past 3 month ) treatment impose protocol . 5 . Any subject botulinum toxin treatment would contraindicate ; know allergy sensitivity medication . 6 . Subjects young 18 year age . Neuromuscularjunction disorder . 7 . Evidence acute pathology neuroimaging . 8 . Axis I diagnosis determined neurologist psychiatrist . 9 . Use Anesthetic medication within two week corticosteroid injection within 4 week enrollment . 10 . Those received botulinum toxin injection past 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Tremor</keyword>
	<keyword>Parkinson</keyword>
	<keyword>botulinum</keyword>
	<keyword>Xeomin</keyword>
</DOC>